News

ASAP Utilities Clinches Prestigious Excel Award at Summit

ASAP Utilities Clinches Prestigious Excel Award at Summit

ASAP Utilities Triumphs at the Global Excel Summit

ASAP Utilities has achieved a remarkable milestone by winning the 'Best Microsoft Excel Add-in' award at the highly prestigious Global Excel Summit. This accolade highlights the dedication and innovation that ASAP Utilities has brought to the Excel community for many years.

A Celebration of Excellence

The Global Excel Summit is renowned as the largest gathering of Excel users and experts worldwide. This event fosters knowledge exchange and skill enhancement among participants, making it an ideal platform for showcasing exceptional talent within the community. The awards presented at the summit include several categories that acknowledge the best among Excel applications and add-ins.

Why ASAP Utilities Stands Out

ASAP Utilities garnered this esteemed award through a meticulous selection process. The winners were decided based on a rigorous system that encompassed public nominations, expert appraisals by a panel of distinguished Excel professionals, and a vote from the global Excel community. ASAP Utilities stood out for its impressive range of tools that significantly boost productivity and enhance efficiency.

One of the key factors driving the popularity of ASAP Utilities is its commitment to helping users optimize their Excel experience. The add-in features a collection of utilities designed to simplify complex tasks, giving users more time to focus on their work. Bastien Mensink, the founder of ASAP Utilities, expressed heartfelt gratitude for this honor, stating, "Winning this award is a tremendous honor and a significant compliment from the Excel community. Since our inception in 1999, we have dedicated ourselves to developing tools that save time and streamline processes in Excel."

A Global Footprint

With almost a million users globally, ASAP Utilities transcends geographical barriers, making it an indispensable resource for Excel enthusiasts across the world. Its availability in ten different languages ensures that users from various backgrounds can access its rich array of features, promoting inclusivity within the community.

Two Editions for Diverse Needs

ASAP Utilities offers two editions to cater to different user needs. The Home & Student Edition is provided free of charge for personal users, students, and charitable entities such as UNICEF and the Red Cross. This makes it easier for emerging learners and organizations to harness the power of Excel without financial constraints. Meanwhile, the Business Edition is available as a one-time purchase, facilitating companies and government institutions to explore its advanced functionalities. To ensure satisfaction, it includes a fully functional 90-day free trial, allowing users to experience the benefits first-hand.

Innovation and Community Engagement

Being an industry leader requires constant innovation and engagement, and ASAP Utilities prides itself on both. The soon-to-be-released tools and updates reflect user feedback and emerging needs within the expanding realm of Excel. As Excel continues to evolve, ASAP Utilities remains committed to developing solutions that not only enhance the user experience but also address current and future demands.

Frequently Asked Questions

What is ASAP Utilities?

ASAP Utilities is an add-in tool for Microsoft Excel that enhances productivity and simplifies complex tasks through a variety of features.

What award did ASAP Utilities win?

ASAP Utilities won the 'Best Microsoft Excel Add-in' award at the Global Excel Summit 2025.

Who can use ASAP Utilities?

Nearly anyone can use ASAP Utilities, as it is available in a free Home & Student Edition for personal use, students, and charities.

How can businesses access ASAP Utilities?

Businesses can purchase the Business Edition, which also offers a 90-day free trial for users to test its features.

In how many languages is ASAP Utilities available?

ASAP Utilities is available in ten different languages, making it accessible to a wide range of users worldwide.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Morgan Stanley Projects Strong Upswing for Consumer Finance

Updated Category News Views 259

Morgan Stanley's Positive Outlook for Consumer Finance Stocks Morgan Stanley has recently made an uplifting adjustment to its outlook on consumer finance stocks, now branding them as "attractive." This decision stems from robust fundamentals and an improved regulatory environment, setting an optimistic tone for the sector. Key Drivers of Change The primary catalysts...

Continue Reading
Significant Board Restructuring at O2Gold Inc. Announced

Updated Category News Views 71

O2Gold Board Announces Key Changes O2Gold Inc. (NEX: OTGO.H), a dedicated mineral exploration company, has recently undergone a significant change in its board structure. The company has announced that Roger Lemaitre has resigned from his position as a director. This decision marks a pivotal moment for O2Gold as it continues to navigate its exploration initiatives....

Continue Reading
Taylor Morrison Launches Holiday Initiative to Support Homeowners

Updated Category News Views 265

Help for Homeowners During the Holidays In a time when financial strain can be prominent, especially during the holidays, Taylor Morrison (NYSE: TMHC) is stepping up to lend a hand. The renowned homebuilder has introduced an initiative designed to support homeowners facing the threat of foreclosure. With the holiday season often heightening financial challenges, the...

Continue Reading
flatexDEGIRO Moves Ahead After Ending BaFin Oversight

Updated Category News Views 188

flatexDEGIRO Ends Special Commissioner Mandate FRANKFURT - flatexDEGIRO AG, a prominent German financial services provider, has officially announced the conclusion of the special commissioner mandate set by the Federal Financial Supervisory Authority (BaFin). This change will take effect on a specified date in the future. The company has made significant strides in...

Continue Reading
Investigating Alvotech's Regulatory Challenges After Stock Drop

Updated Category News Views 125

Alvotech Faces Scrutiny over Manufacturing Issues National shareholder rights firm Hagens Berman is currently analyzing Alvotech (NASDAQ: ALVO) regarding potential misrepresentations in their disclosures tied to manufacturing operations and the regulatory status of their primary biosimilar candidate, AVT05. Impact of FDA's Complete Response Letter The investigation stems...

Continue Reading